Qassur Pharmaceuticals Private Limited
Founded in 2023 and headquartered in Kerala, India.
2023 | Thrissur, Kerala (India) | Active
Qassur Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 1 Year 9 Months
About Qassur Pharmaceuticals
Qassur Pharmaceuticals Private Limited (QPPL) is a Private Limited Indian Non-Government Company incorporated in India on 04 May 2023 (One year and nine months 26 days old ). Its registered office is in Thrissur, Kerala, India.
The Company is engaged in the Paper Industry.
The Company's status is Active It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Bindhu, Narayanan Sini, Vigini Vikraman, and One other member serve as directors at the Company.
Company Details
- Location
Thrissur, Kerala, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U21002KL2023PTC081237
- Company No.
081237
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
04 May 2023
- Date of AGM
-
- Date of Balance Sheet
-
- Listing Status
Unlisted
- ROC Code
Roc Ernakulam
Industry
Paper
Who are the key members and board of directors at Qassur Pharmaceuticals?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Narayanan Sini  | Managing Director | 04-May-2023 | Current |
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Bindhu | Director | 04-May-2023 | Current |
| Vigini Vikraman | Director | 04-May-2023 | Current |
| Reshma Ravindren | Director | 06-Jul-2024 | Current |
Financial Performance of Qassur Pharmaceuticals.
Enhance accessibility to Qassur Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Qassur Pharmaceuticals?
Unlock access to Qassur Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Qassur Pharmaceuticals?
Unlock and access historical data on people associated with Qassur Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Qassur Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Qassur Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.